Bionano Genomics interim CEO Albert Luderer acquires 4,000 common shares worth $4,860
BNGO•Interim CEO acquires shares
- Bionano Genomics interim chief executive Albert Luderer bought 4,000 common shares at $1.22 each.
- Holding rose to 4,000 shares, owned indirectly through a Traditional IRA.
